Cancer Drugmaker Tesaro Is Said to Explore Potential Sale

Bookmark
(Bloomberg) -- Tesaro Inc., a drugmaker whose shares tumbled this month after disclosing disappointing clinical trial results, is exploring a sale, according to people familiar with the matter.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.